mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |